第一单位：
Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
作者：
Dyah L,Dewi [1]
;
Soumya R,Mohapatra [1]
;
Saioa,Blanco Cabañes [1]
;
Isabell,Adam [1]
;
Luis F,Somarribas Patterson [1]
;
Bianca,Berdel [1]
;
Masroor,Kahloon [1]
;
Loreen,Thürmann [2]
;
Stefanie,Loth [2]
;
Katharina,Heilmann [3]
;
Dieter,Weichenhan [3]
;
Oliver,Mücke [3]
;
Ines,Heiland [4]
;
Pauline,Wimberger [5]
;
Jan Dominik,Kuhlmann [5]
;
Karl-Heinz,Kellner [6]
;
Sarah,Schott [7]
;
Christoph,Plass [3]
;
Michael,Platten [8]
;
Clarissa,Gerhäuser [3]
;
Saskia,Trump [2]
;
Christiane A,Opitz [9]
作者单位：
Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
[1]
Department of Environmental Immunology, Helmholtz Centre for Environmental Research - UFZ , Leipzig, Germany.
[2]
Epigenomics and Cancer Risk Factors, German Cancer Research Center (DKFZ) , Heidelberg, Germany.
[3]
Department of Arctic and Marine Biology, UiT Arctic University of Norway , Tromsø, Norway.
[4]
Department of Gynecology and Obstetrics, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; National Center for Tumor Diseases (NCT), partner site Dresden, Dresden, Germany; German Cancer Consortium (DKTK), Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.
[5]
Neuroimmun GmbH , Karlsruhe, Germany.
[6]
Department of Obstetrics and Gynecology, University of Heidelberg , Heidelberg, Germany.
[7]
Neurology Clinic and National Center for Tumor Diseases, University Hospital of Heidelberg, Heidelberg, Germany; Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
[8]
Brain Cancer Metabolism Group, German Cancer Research Center (DKFZ), Heidelberg, Germany; Neurology Clinic and National Center for Tumor Diseases, University Hospital of Heidelberg, Heidelberg, Germany.
[9]
DOI
10.1080/2162402X.2016.1274477
PMID
28344890
发布时间
2021-01-12
换一批
